Sang-Goo Shin

955 total citations
47 papers, 752 citations indexed

About

Sang-Goo Shin is a scholar working on Endocrinology, Diabetes and Metabolism, Oncology and Molecular Biology. According to data from OpenAlex, Sang-Goo Shin has authored 47 papers receiving a total of 752 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Endocrinology, Diabetes and Metabolism, 11 papers in Oncology and 10 papers in Molecular Biology. Recurrent topics in Sang-Goo Shin's work include Diabetes Treatment and Management (8 papers), Drug Transport and Resistance Mechanisms (7 papers) and Pharmacological Effects and Toxicity Studies (6 papers). Sang-Goo Shin is often cited by papers focused on Diabetes Treatment and Management (8 papers), Drug Transport and Resistance Mechanisms (7 papers) and Pharmacological Effects and Toxicity Studies (6 papers). Sang-Goo Shin collaborates with scholars based in South Korea, United States and Ethiopia. Sang-Goo Shin's co-authors include In‐Jin Jang, Kyung‐Sang Yu, Joo‐Youn Cho, Seo Hyun Yoon, Kyoung Soo Lim, SoJeong Yi, Tae‐Eun Kim, Arthur J. Atkinson, Steven M. Belknap and Bo‐Hyung Kim and has published in prestigious journals such as Journal of Cerebral Blood Flow & Metabolism, Psychopharmacology and Cancer Letters.

In The Last Decade

Sang-Goo Shin

46 papers receiving 730 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sang-Goo Shin South Korea 17 193 141 127 112 96 47 752
Charles Locke United States 20 192 1.0× 136 1.0× 152 1.2× 95 0.8× 93 1.0× 54 1.4k
Daniël M. Jonker Denmark 10 224 1.2× 109 0.8× 99 0.8× 98 0.9× 98 1.0× 19 890
Eric Snoeck Belgium 18 176 0.9× 100 0.7× 137 1.1× 114 1.0× 39 0.4× 44 1.1k
Mohamed E. E. Shams Egypt 15 187 1.0× 140 1.0× 171 1.3× 58 0.5× 56 0.6× 32 904
Scott R. Hamann United States 16 207 1.1× 84 0.6× 90 0.7× 138 1.2× 140 1.5× 37 929
Donald W. Everett United States 11 162 0.8× 52 0.4× 177 1.4× 122 1.1× 76 0.8× 12 753
Stefan Viktor Vormfelde Germany 17 261 1.4× 167 1.2× 131 1.0× 247 2.2× 39 0.4× 37 907
Akihiro Tanaka Japan 19 316 1.6× 44 0.3× 94 0.7× 156 1.4× 63 0.7× 78 1.1k
Yanling He China 18 227 1.2× 338 2.4× 99 0.8× 250 2.2× 61 0.6× 41 1.0k
Stephen D. Wise Singapore 16 168 0.9× 228 1.6× 244 1.9× 101 0.9× 35 0.4× 29 985

Countries citing papers authored by Sang-Goo Shin

Since Specialization
Citations

This map shows the geographic impact of Sang-Goo Shin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sang-Goo Shin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sang-Goo Shin more than expected).

Fields of papers citing papers by Sang-Goo Shin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sang-Goo Shin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sang-Goo Shin. The network helps show where Sang-Goo Shin may publish in the future.

Co-authorship network of co-authors of Sang-Goo Shin

This figure shows the co-authorship network connecting the top 25 collaborators of Sang-Goo Shin. A scholar is included among the top collaborators of Sang-Goo Shin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sang-Goo Shin. Sang-Goo Shin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lee, Jongtae, Donghoon Shin, Hyewon Jeon, et al.. (2014). Pharmacodynamics, Pharmacokinetics, and Tolerability of Intravenous or Subcutaneous GC1113, a Novel Erythropoiesis-Stimulating Agent. Clinical Drug Investigation. 34(6). 373–382. 2 indexed citations
2.
Kim, Tae‐Eun, Kyoung Soo Lim, Joo‐Youn Cho, et al.. (2013). Pharmacokinetic and Pharmacodynamic Properties of a New Long-Acting Granulocyte Colony-Stimulating Factor (HM10460A) in Healthy Volunteers. BioDrugs. 27(2). 149–158. 7 indexed citations
3.
Kim, Tae‐Eun, Namyi Gu, Seo Hyun Yoon, et al.. (2012). Tolerability and Pharmacokinetics of a New P-Glycoprotein Inhibitor, HM30181, in Healthy Korean Male Volunteers: Single- and Multiple-Dose Randomized, Placebo-Controlled Studies. Clinical Therapeutics. 34(2). 482–494. 16 indexed citations
4.
Shin, Donghoon, SeungHwan Lee, Kyoung Soo Lim, et al.. (2012). Pharmacokinetic study of single and multiple oral administrations of 2 mg dienogest in healthy Korean women. Contraception. 87(6). 750–755. 7 indexed citations
5.
6.
Shin, Dongseong, SeungHwan Lee, Joo‐Youn Cho, et al.. (2012). Multiple-dose pharmacokinetics of fesoterodine sustained-release in healthy Korean volunteers. International Journal of Clinical Pharmacology and Therapeutics. 50(10). 722–728. 1 indexed citations
7.
Yi, SoJeong, Sung Eun Kim, Seo Hyun Yoon, et al.. (2012). Comparative Pharmacokinetics of HD203, a Biosimilar of Etanercept, with Marketed Etanercept (Enbrel®). BioDrugs. 26(3). 177–184. 30 indexed citations
8.
Yi, SoJeong, Tae‐Eun Kim, Seo Hyun Yoon, et al.. (2011). Pharmacokinetic Interaction of Fimasartan, a New Angiotensin II Receptor Antagonist, With Amlodipine in Healthy Volunteers. Journal of Cardiovascular Pharmacology. 57(6). 682–689. 43 indexed citations
9.
10.
11.
Yi, SoJeong, Hyewon Jeon, Seo Hyun Yoon, et al.. (2011). Pharmacokinetics and Pharmacodynamics of Oral Tolvaptan Administered in 15- to 60-mg Single Doses To Healthy Korean Men. Journal of Cardiovascular Pharmacology. 59(4). 315–322. 20 indexed citations
12.
Lee, SeungHwan, Wan Beom Park, Seo Hyun Yoon, et al.. (2011). Immunogenicity and safety of a single intramuscular dose of a diphtheria–tetanus toxoid (Td) vaccine (GC1107) in Korean adults. Vaccine. 29(44). 7638–7643. 3 indexed citations
13.
14.
Lee, SeungHwan, Seo Hyun Yoon, Joo‐Youn Cho, et al.. (2010). Relative Bioavailability and Tolerability of Two Formulations of Bicalutamide 50-mg Tablets: A Randomized-Sequence, Open-Label, Two-Period Crossover Study in Healthy Korean Male Subjects. Clinical Therapeutics. 32(14). 2496–2501. 1 indexed citations
15.
Kim, Kyu-pyo, Bo‐Hyung Kim, Kyoung Soo Lim, et al.. (2009). Potential interactions between cilostazol and probucol: A two-part, single-dose, open-label study in healthy Korean male volunteers. Clinical Therapeutics. 31(10). 2098–2106. 7 indexed citations
16.
17.
Kim, Euitae, Kyung‐Sang Yu, Joo‐Youn Cho, et al.. (2006). Effects of DRD2 and CYP2D6 genotypes on delta EEG power response to aripiprazole in healthy male volunteers: a preliminary study. Human Psychopharmacology Clinical and Experimental. 21(8). 519–528. 9 indexed citations
18.
Cho, Joo‐Youn, Hyeong-Seok Lim, Jae‐Yong Chung, et al.. (2004). HAPLOTYPE STRUCTURE AND ALLELE FREQUENCIES OF CYP2B6 IN A KOREAN POPULATION. Drug Metabolism and Disposition. 32(12). 1341–1344. 42 indexed citations
19.
Cho, Joo‐Youn, et al.. (2002). Simple and sensitive determination of the new antitumor drug CKD-602 in human plasma by liquid chromatography. Journal of Chromatography B. 784(1). 25–31. 5 indexed citations
20.
Ambre, John, Steven M. Belknap, John E. Nelson, et al.. (1988). Acute tolerance to cocaine in humans. Clinical Pharmacology & Therapeutics. 44(1). 1–8. 99 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Charles Locke Breakdown of academic impact, for papers by Daniël M. Jonker Breakdown of academic impact, for papers by Eric Snoeck Breakdown of academic impact, for papers by Mohamed E. E. Shams Breakdown of academic impact, for papers by Scott R. Hamann Breakdown of academic impact, for papers by Donald W. Everett Breakdown of academic impact, for papers by Stefan Viktor Vormfelde Breakdown of academic impact, for papers by Akihiro Tanaka Breakdown of academic impact, for papers by Yanling He Breakdown of academic impact, for papers by Stephen D. Wise
Rankless by CCL
2026